Accès gratuit
Med Sci (Paris)
Volume 21, Numéro 6-7, Juin–Juillet 2005
Page(s) 641 - 647
Section M/S revues
Publié en ligne 15 juin 2005
  1. Unified nomenclature for the semaphorins/collapsins. Nomenclature committee. Cell 1999; 97 : 551–2.
  2. Winberg ML, Noordemeer JN, Tamagnone L, et al. Plexin A is a neuronal semaphorin receptor that controls axon guidance. Cell 1998; 95 : 903–16.
  3. Kolodkin AL, Levengood DV, Rowe EG, et al. Neuropilin is a semaphorin III receptor. Cell 1997; 90 : 753–62.
  4. Chen H, Chedotal A, He Z, et al. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 1997; 19 : 547–59.
  5. Tamagnone L, Artigiani S, Chen H, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999; 99 : 356–61.
  6. Gu C, Yoshida Y, Livet J, et al. Semaphorin 3E and Plexin-D1 control vascular pattern independently of neuropilins. Science 2005; 307 : 265–8.
  7. Kanter DB, Chivatakarn O, Peer KL, et al. Semaphorin5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 2004; 44 : 961–75.
  8. Castellani V, Rougon G. Control of semaphorin signaling. Curr Opin Neurobiol 2002; 12 : 532–41.
  9. Serini G, Valdembri D, Zanivan S, et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003; 424 : 391–7.
  10. Pasterkamp R, Peschon J, Spriggs M, Kolodkin A. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 2003; 424 : 398–405.
  11. Pasterkamp R, Kolodkin A. Semaphorin junction : macking tracks toward neural connectivity. Curr Opin Neurobiol 2003; 13 :79–89.
  12. Bagnard D, Sainturet N, Meyronet D, et al. Differential MAP kinases activation during Semaphorin3A-induced repulsion or apoptosis of neural progenitor cells. Mol Cell Neurosci 2004; 25 : 722–31.
  13. Eickholt BJ, Walsh FS, Doherty P. An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J Cell Biol 2002; 157 : 211–7.
  14. He Z, Wang KC, Koprivica V, et al. Knowing how to navigate : mechanisms of signaling in the nervous system. Sci STKE 2002; 119 : RE1.
  15. Skutella T, Nitsch R. New molecules for hippocampal development. Trends Neurosci 2001; 24 : 107–13.
  16. Gavazzi I. Semaphorin-neuropilin-1 interactions in plasticity and regeneration of adult neurons. Cell Tissue Res 2001; 305 : 275–84.
  17. Behar O, Golden JA, Mashimo H, et al. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 1996; 383 : 525–8.
  18. Takashima S, Kitakaze M, Asakura M, et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs development yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 2002; 99 : 3657–62.
  19. Soker S, Takashima S, Miao H, et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92 : 735–45.
  20. Miao HQ, Soker S, Feiner L, et al. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility : Functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 1999; 146 : 233–42.
  21. Konno R. Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray. Hum Cell 2001; 14 : 261–6.
  22. Christensen CR, Klingelhofer J, Tarabykina S, et al. Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res 1998; 58 : 1238–44.
  23. Correa RG, Sasahara RM, Bengton MH, et al. Human semaphorin 6B ([HSA]SEMA6B), a novel human class 6 semaphorin gene : Alternative splicing and all-trans-retinoic acid-dependent downregulation in glioblastoma cell lines. Genomics 2001; 73 : 343–8.
  24. Granziero L, Circosta P, Scielzo C, et al. CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes. Blood 2003; 101 : 1962–9.
  25. Giordano S, Corso S, Conrotto P, et al. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol 2002; 4 : 720–4.
  26. Basile J, Barac A, Zhu T, et al. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 2004; 65 : 5212–24.
  27. Conrotto P, Valdembri D, Corso S, et al. Sema4D induces angiogenesis through Met recruitment by plexin B1. Blood 2005, 4 janvier, online.
  28. Woodhouse E, Fisher A, Bandle R, et al. Drosophila screening model for metastasis : Semaphorin 5c is required for l(2)gl cancer phenotype. Proc Natl Acad Sci USA 2003; 100 : 11463–8.
  29. Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3 : identification and evaluation of the resident candidate tumor suppressor genes. The international lung cancer chromosome 3p21.3 tumor suppressor gene consortium. Cancer Res 2000; 60 : 6116–33.
  30. Roche J, West J, Gemmill R, Drabkin H. Chromosome 3p, gènes suppresseurs de tumeurs et gènes de sémaphorines en 3p21.3. Med Sci (Paris) 1998; 14 : 283–90.
  31. Todd M, Xiang R, Garcia D, et al. An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. Oncogene 1996; 13 : 2387–96.
  32. Brambilla E, Constantin B, Drabkin H, Roche J. Semaphorin SEMA3F localization in malignant human lung and cell lines : A suggested role in cell adhesion and cell migration. Am J Pathol 2000; 156 : 939–50.
  33. Lantuéjoul S, Constantin B, Drabkin H, et al. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumors, and cell lines. J Pathol 2003; 200 : 336–47.
  34. Tomizawa Y, Sekido Y, Kondo M, et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA 2001; 98 : 13954–9.
  35. Nasarre P, Kusy S, Constantin B, et al. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Neoplasia 2005 (sous presse).
  36. Nasarre P, Constantin B, Rouhaud L, et al. Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. Neoplasia 2003; 5 : 83–92.
  37. Xiang R, Davalos AR, Hensel CH, et al. Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res 2002; 62 : 2637–43.
  38. Kessler O, Shraga-Heled N, Lange T, et al. Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res 2004; 64 : 1008–15.
  39. Kusy S, Nasarre P, Chan D, et al. Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Neoplasia 2005 (sous presse).
  40. Bielenberg DR, Hida Y, Shimizu A, et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest 2004; 114 : 1260–71.
  41. Ochi K, Mori T, Toyama Y, et al. Identification of semaphorin3B as a direct target of p53. Neoplasia 2002; 4 : 82–7.
  42. Castro-Rivera E, Ran S, Thorpe P, Minna JD. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc Natl Acad Sci USA 2004; 101 : 11432–7.
  43. Tse C, Xiang RH, Bracht T, Naylor SL. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res 2002; 62 : 542–6.
  44. Xiang R, Hensel C, Garcia D, et al. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 1996; 32 : 39–48.
  45. Kuroki T, Trapasso F, Yendamuri S, et al. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res 2003; 63 : 3352–5.
  46. Bachelder RE, Lipscomb EA, Lin X, et al. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 2003; 63 : 5230–3.
  47. Dorfman D, Shahsafaei A, Nadler L, Freeman G. The leucocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin’s lymphomas. Am J Pathol 1998; 153 : 255–62.
  48. Miao HQ, Lee P, Lin H, et al. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J 2000; 14 : 2532–9.
  49. Gagnon ML, Bielenberg DR, Gechtman Z, et al. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor : In vivo expression and antitumor activity. Proc Natl Acad Sci USA 2000; 97 : 2573–8.
  50. Chang CC, Shih JY, Jeng YM, et al. Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst 2004; 96 : 364–75.
  51. Prasad A, Fernandis AZ, Rao Y, Ganju K. Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells. J Biol Chem 2004; 279 : 9115–24.
  52. Surawska H, Ma PC, Salgia R. The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 2004; 15 : 419–33.
  53. Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 2004; 4 : 978–87.
  54. Lu X, Le Noble F, Yuan L, et al. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 2004; 432 : 179–86.
  55. Sekido Y, Bader S, Latif F, et al. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci USA 1996; 93 : 4120–5.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.